Medical application of highly expressed TrkB as novel target to inhibition of pancreatic cancer metastasis
A high-expression, pancreatic cancer technology, applied to medical preparations containing active ingredients, pharmaceutical formulas, anti-tumor drugs, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0035] The applicant's research analysis and experiments are described in detail below.
[0036] Tumor metastasis is a multi-step, inefficient process. The impact of fluid mechanics in blood vessels and lymphatic vessels, hypoxia, lack of nutrition, immune system attack and uncomfortable tissue microenvironment will all pose a fatal threat to metastatic tumor cells. Therefore, the applicant realized that the distant metastasis of tumor cells is not accomplished by a single cell alone, but only by aggregating to form a large aggregate (cell aggregate, usually >50 cells) to form a moving tumor microenvironment (moving microenvironment). Guaranteed transfer validity. Our previous studies found that TrkB of the nerve growth factor receptor family is necessary to maintain the formation of this large aggregate. For example, we found that TrkB can phosphorylate the cytoskeleton protein β-Catenin by activating its downstream protein kinase C (protein kinase C; PKC) signaling pathway...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


